Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
0.1104
+0.0029 (2.70%)
At close: Jun 30, 2026, 4:00 PM EDT
0.1010
-0.0094 (-8.51%)
After-hours: Jun 30, 2026, 7:59 PM EDT
Liminatus Pharma Market Cap
Liminatus Pharma has a market cap or net worth of $4.95 million as of June 30, 2026. Its market cap has decreased by -98.68% in one year.
Market Cap
4.95M
Enterprise Value
4.36M
1-Year Change
-98.68%
Ranking
Category
Stock Price
$0.11
Market Cap Chart
Since May 26, 2021, Liminatus Pharma's market cap has decreased from $346.04M to $4.95M, a decrease of -98.57%. That is a compound annual growth rate of -56.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 4.95M | -69.99% |
| Dec 31, 2025 | 16.51M | -79.39% |
| Dec 31, 2024 | 80.10M | 6.12% |
| Dec 27, 2023 | 75.48M | -78.38% |
| Dec 30, 2022 | 349.14M | 3.48% |
| Dec 31, 2021 | 337.41M | -2.49% |
| May 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dermata Therapeutics | 5.19M |
| PMGC Holdings | 5.18M |
| Processa Pharmaceuticals | 5.12M |
| Alaunos Therapeutics | 5.04M |
| CollPlant Biotechnologies | 4.80M |
| TransCode Therapeutics | 4.72M |
| GeoVax Labs | 4.58M |
| Alzamend Neuro | 4.57M |